Skip to content

Evaluation of non-contrast T2-prepared radial mDIXON 3D angiography (REACT VANE) in pediatric MRI

Evaluation of non-contrast T2-prepared radial mDIXON 3D angiography (REACT VANE) in pediatric MRI - REACT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00029385
Enrollment
90
Registered
2022-06-28
Start date
2023-02-13
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children and adolescents receiving contrast-enhanced MRI for clinical indication.

Interventions

Group 1: Patients will have additional MR sequences (REACT VANE sequence and T1-FFE contrast angiography, if applicable) measured as part of their clinically indicated contrast-enhanced MRI. This will

Sponsors

Universitätsklinikum Tübingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Months to 20 Years

Inclusion criteria

Inclusion criteria: • Male and female patients. • Referral from pediatrics with a clinical indication for a contrast-enhanced MRI scan. • Examination on the Philips Ingenia 1.5 Tesla. • Presence of all necessary laboratory parameters (creatinine/GFR according to internal guidelines of the UKT). • No need for anesthesia for the MRI examination. • Written consent for the study from the patient and/or guardian.

Exclusion criteria

Exclusion criteria: • All MR-relevant contraindications. • Contraindication to contrast agent administration (gadolinium). • Need for anesthesia for MRI examination. • Patient non-compliance for MRI examination or for study-related extension of MRI examination time. • No written informed consent for the study from the patient and/or guardian.

Design outcomes

Primary

MeasureTime frame
To establish a qualitative and quantitative comparison based on various criteria (resolution and diameters of co-imaged vessels as well as detection of vascular anomalies and normovariances) to evaluate the image quality of the study-related newly implemented sequence (REACT VANE) in comparison to standard MR angiography or contrast dynamics.

Secondary

MeasureTime frame
• Comparative determination of occurring motion artifacts. • Determination of the rate of examinations with potentially saved contrast medium (no significant difference between contrast medium-free and contrast medium-enhanced angiography).

Countries

Germany

Contacts

Public ContactJakob Spogis

Universitätsklinikum Tübingen, Radiologie, Diagnostische & Interventionelle Radiologie

jakob.spogis@med.uni-tuebingen.de07071-29-68428

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026